Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (2015 - 2024)
Corbus Pharmaceuticals Holdings' EBITDA Margin was -6236.69% in FY2021, down 3146.03 percentage points from -3090.66% in FY2020.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (2015 - 2024) Analysis & Trends
From FY2015 onward, Corbus Pharmaceuticals Holdings has reported EBITDA Margin for 6 years.
- EBITDA Margin shows a four-year change of -4912.73 percentage points (FY2017 to FY2021).
- The FY2021 figure marks the lowest annual EBITDA Margin in data going back to FY2015.
- Per Business Quant data, EBITDA Margin in earlier years was -3090.66% in FY2020 (-2879.38 pp), -211.28% in FY2019 (+955.26 pp), -1166.54% in FY2018 (+157.42 pp) and -1323.96% in FY2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.86 Bn | 1,133.45 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 632.18 Bn | 550.71 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.53 Bn | 476.64 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 378.03 Bn | 332.41 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 303.09 Bn | 267.08 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 266.38 Bn | 240.07 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 241.24 Bn | 196.64 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.68 Bn | 167.88 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 172.22 Bn | 118.87 Bn | 10.94 Bn | 39.16% |
| 10 | Corbus Pharmaceuticals Holdings | 54.28 Mn | -462.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -1,284.86% |
| Jun 30, 2024 | -1,181.68% |
| Sep 30, 2023 | -4,193.57% |
| Jun 30, 2023 | -3,362.45% |
| Sep 30, 2021 | -13,862.36% |
| Jun 30, 2021 | -11,909.66% |
| Mar 31, 2021 | -2,311.08% |
| Dec 31, 2020 | -3,092.93% |
| Sep 30, 2020 | -2,744.29% |
| Jun 30, 2020 | -13,207.28% |
| Mar 31, 2020 | -1,677.91% |
| Dec 31, 2019 | -1,045.92% |
| Sep 30, 2019 | -962.97% |
| Jun 30, 2019 | 6.40% |
| Mar 31, 2019 | -1,398.44% |
| Dec 31, 2018 | -904.67% |
| Sep 30, 2018 | -1,353.56% |
| Jun 30, 2018 | -1,437.29% |
| Mar 31, 2018 | -1,239.74% |
| Sep 30, 2017 | -857.72% |
API Access
Corbus Pharmaceuticals Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();